Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

T-Lymphocyte Subsets

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on T-Lymphocyte Subsets:

Pubmed Logo
Cutting Edge: Responder T cells regulate human DR+ effector regulatory T cell activity via granzyme B.
MHC class II expression identifies an effector subset of human...
11th November, 2009
Laboratory of Molecular Immunology, Center for Neurologic Diseases, J Immunol. 2009 Oct 15;183(8):4843-7.
DOI Direct Link
A cis-acting regulatory variant in the IL2RA locus.
The mechanism for the association of type 1 diabetes (T1D) with IL2RA...
11th November, 2009
Endocrine Genetics Lab, The McGill University Health Center and Montreal J Immunol. 2009 Oct 15;183(8):5158-62. Epub 2009 Sep 30.
DOI Direct Link
Marked induction of the helix-loop-helix protein Id3 promotes the gammadelta T cell fate and renders their functional maturation Notch independent.
alphabeta and gammadelta T cells arise from a common thymocyte progenitor...
7th November, 2009
Blood Cell Development and Cancer Keystone, Immune Cell Development and Immunity. 2009 Oct 16;31(4):565-75.
DOI Direct Link
Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases.
Interferon-gamma (IFN-gamma) is an important mediator of immunity and...
7th November, 2009
Arthritis and Tissue Degeneration Program, Hospital for Special Surgery, Immunity. 2009 Oct 16;31(4):539-50.
DOI Direct Link
Is antigen specificity of autoreactive T cells the key to islet entry?
It has been widely hypothesized that pancreatic islet infiltrates include...
7th November, 2009
Department of Medicine, Diabetes Center, University of California, San Immunity. 2009 Oct 16;31(4):534-6.
DOI Direct Link

View more research publications.

Press Releases About T-Lymphocyte Subsets:

BioPortfolio Logo
CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 9th November, 2009 CEL-SCI Corporation
VIENNA, Va., Nov. 9 /PRNewswire-FirstCall/ -- CEL-SCI Corporation (NYSE Amex: CVM) announced today that Dr. Kenneth S. Rosenthal, Professor of Immunology and Microbiology of Northeastern Ohio
CEL-SCI Presents Data at American College of Rheumatology Conference Which Suggests that CEL-2000 Has Potential to Slow Damage Caused by Rheumatoid Arthritis 19th October, 2009 CEL-SCI Corporation
VIENNA, Va., Oct. 19 /PRNewswire-FirstCall/ -- CEL-SCI Corporation (NYSE Amex: CVM) announced today the presentation of new rheumatoid arthritis data at the American College of Rheumatology's
New Report Just Published: World Multiple Myeloma Therapeutics Market Report 7th July, 2009 Reportlinker
NEW YORK, July 7 /PRNewswire/ -- Reportlinker.com just added a new market research report to its catalogue. World Multiple Myeloma Therapeutics Market http://www.reportlinker.com/p0119496/World
CEL-SCI Files Patent Application to Support Company's Treatment for More Virulent Strain of H1N1 Swine and Other Influenza Viruses 24th June, 2009 CEL-SCI Corporation
VIENNA, Va., June 24 /PRNewswire-FirstCall/ -- CEL-SCI CORPORATION (NYSE AMEX: CVM) announced today that it has filed a provisional U.S. patent application covering its L.E.A.P.S.(TM) immune therapy
CEL-SCI Expands Testing of Its Vaccine to Determine Efficacy Against More Virulent Strain of H1N1 Swine and Other Influenza Viruses 9th June, 2009 CEL-SCI Corporation
VACCINE USING L.E.A.P.S.(TM) TECHNOLOGY PLATFORM IS DESIGNED TO ADDRESS MUTATED FORMS OF SWINE INFLUENZA AND CAN ACT AS BOTH PREVENTATIVE AND THERAPEUTIC VACCINE VIENNA, Va., June 9 /PRNewswire

T-Lymphocyte Subsets Clinical Trials:

Clinical Trials Logo
An Analysis of Peripheral Blood T Cell Subsets on Rheumatoid Arthritis

T-Lymphocyte Subsets Patents:

USPTO Logo
US Patent No.Title
5849586 Infective protein delivery system
5997880 Method for alleviating varicella related post-herpetic neuralgia
6071512 Infective protein delivery system
6090625 Method of increasing the relative number of CD34.sup.+ cells in a cell population
6133029 Replication defective viral vectors for infecting human cells

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for T-Lymphocyte Subsets scientists - we have details of around 1684 individuals working on T-Lymphocyte Subsets .


This page has been viewed 281 times
Recent Search Terms used to find this page: ror wiki lymphocytes | discovery of T-lymphocyte | J Exp Med. 2008 Aug 4 205(8) 1763-73. Epub 2008 Jul 28. | J Exp Med. 2008 Aug 4 205(8) 1763-73. Epub 2008 Jul 28. | J Exp Med. 2008 Aug 4 205 8 1763-73. Epub 2008 Jul 28. | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for T-Lymphocyte Subsets across BioPortfolio, or for T-Lymphocyte Subsets Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.